05/13/2024 12:40 PM | Aquestive Therapeutics (Issuer) Jenkins Abigail L. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2024 12:40 PM | Aquestive Therapeutics (Issuer) Wargacki Stephen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/07/2024 8:08 PM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 3:21 PM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/07/2024 3:23 PM | Aquestive Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024 8:30 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/26/2024 8:20 AM | Aquestive Therapeutics (Issuer) Jenkins Abigail L. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
|
04/24/2024 5:23 AM | Aquestive Therapeutics (Filer) Aquestive Therapeutics (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
04/24/2024 5:25 AM | Aquestive Therapeutics (Filer) Aquestive Therapeutics (Filer)
| Form 424B2 Transaction specifc information for a delayed shelf offering | |
04/23/2024 11:15 PM | Aquestive Therapeutics (Filer)
| Form EFFECT | |
04/03/2024 4:27 PM | Aquestive Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
04/01/2024 5:21 PM | Aquestive Therapeutics (Subject) Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G | |
04/01/2024 7:15 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 1:30 PM | Aquestive Therapeutics (Issuer) Schobel Alexander Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 8:56 PM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/12/2024 12:45 PM | Aquestive Therapeutics (Issuer) Schobel Alexander Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 12:46 PM | Aquestive Therapeutics (Issuer) Jung Cassie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 12:46 PM | Aquestive Therapeutics (Issuer) Wargacki Stephen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 12:47 PM | Aquestive Therapeutics (Issuer) TOTH A ERNEST JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 12:47 PM | Aquestive Therapeutics (Issuer) BRAENDER LORI J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 12:47 PM | Aquestive Therapeutics (Issuer) Boyd Peter E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 12:47 PM | Aquestive Therapeutics (Issuer) Barber Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 9:34 AM | Aquestive Therapeutics (Issuer) Wargacki Stephen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 9:35 AM | Aquestive Therapeutics (Issuer) Boyd Peter E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 9:35 AM | Aquestive Therapeutics (Issuer) Jung Cassie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 9:35 AM | Aquestive Therapeutics (Issuer) Barber Daniel (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 9:35 AM | Aquestive Therapeutics (Issuer) Kraus Carl N (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 9:36 AM | Aquestive Therapeutics (Issuer) Schobel Alexander Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 9:36 AM | Aquestive Therapeutics (Issuer) TOTH A ERNEST JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/11/2024 9:36 AM | Aquestive Therapeutics (Issuer) BRAENDER LORI J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 4:09 PM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/05/2024 4:12 PM | Aquestive Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/14/2024 2:24 PM | Aquestive Therapeutics (Subject) ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G | |
12/08/2023 9:46 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 7:51 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 4:04 PM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 4:20 PM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/06/2023 4:22 PM | Aquestive Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 7:45 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2023 11:04 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/01/2023 11:15 PM | Aquestive Therapeutics (Filer)
| Form EFFECT | |
Who are Nvidia’s Silent Partners? (Ad) Nvidia recently became just the third $2 trillion company.
But Nvidia can’t do everything by itself. I call these Nvidia’s “Silent Partners.” |
09/20/2023 3:39 PM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/11/2023 12:14 PM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/09/2023 4:22 PM | Aquestive Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/02/2023 7:22 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/27/2023 8:23 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/29/2023 8:05 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2023 12:41 PM | Aquestive Therapeutics (Issuer) BROWN GREGORY B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 11:26 AM | Aquestive Therapeutics (Issuer) COSTA SANTO J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 11:26 AM | Aquestive Therapeutics (Issuer) Taglietti Marco (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 11:27 AM | Aquestive Therapeutics (Issuer) MORRIS TIMOTHY E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 11:28 AM | Aquestive Therapeutics (Issuer) Krop Julie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 11:24 AM | Aquestive Therapeutics (Issuer) Cochran John (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/23/2023 8:54 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2023 8:06 AM | Aquestive Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |